Literature DB >> 8402446

Atypical adenomatous hyperplasia of the lung and its differentiation from adenocarcinoma. Characterization of atypical cells by morphometry and multivariate cluster analysis.

M Mori1, R Chiba, T Takahashi.   

Abstract

BACKGROUND: Atypical adenomatous hyperplasia (AAH) of the human lung is considered to be an important lesion preceding adenocarcinoma, but its difference from well-differentiated adenocarcinomas is so subtle as to cause diagnostic uncertainty. In view of this, the authors undertook to establish reproducible microscopic criteria for AAH, Type II pneumocyte type, and Clara cell type adenocarcinomas.
METHODS: Twelve-parameter morphometry of atypical cells was performed on 97 lesions selected from 303 surgical specimens of lung by routine microscopic examination: all were considered by premorphometry examination to correspond to one of the above three diseases. Measurements were performed on photomicrographs using a digital image analyzer. The data of morphometry were subjected to 12-variate cluster analysis using a mainframe computer.
RESULTS: It was demonstrated that the lesions were classifiable into three groups: Cluster 1 (Type II cell adenocarcinoma and AAH), Cluster 2 (AAH), and Cluster 3 (Clara cell adenocarcinoma). Whereas the latter two were created as homogeneous clusters, Cluster 1 was a mixture of Type II tumors and AAH.
CONCLUSIONS: AAH in the strict sense of the word is definable by the features of those classified into Cluster 2, with atypia milder than overt adenocarcinomas. These AAH are likely to correspond to one of the steps of carcinogenesis forgoing the final one. The lesions, diagnosed as AAH before morphometry and being assigned to Cluster 1 and therefore not separable from Type II carcinoma, are considered to have been Type II carcinoma from the very beginning, which were however underdiagnosed in routine microscopic examination.

Entities:  

Mesh:

Year:  1993        PMID: 8402446     DOI: 10.1002/1097-0142(19931015)72:8<2331::aid-cncr2820720808>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

Review 2.  Pulmonary preinvasive neoplasia.

Authors:  K M Kerr
Journal:  J Clin Pathol       Date:  2001-04       Impact factor: 3.411

3.  Atypical adenomatous hyperplasia of the lung: a clinicopathological study of 118 cases including cases with multiple atypical adenomatous hyperplasia.

Authors:  R Nakahara; T Yokose; K Nagai; Y Nishiwaki; A Ochiai
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

4.  Expression of peptidyl-glycine alpha-amidating mono-oxygenase (PAM) enzymes in morphological abnormalities adjacent to pulmonary tumors.

Authors:  A Martínez; A M Treston; L Saldise; L M Montuenga; R I Linnoila
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

5.  Alveolar adenoma of the lung: further characterization of this uncommon tumour.

Authors:  P Oliveira; J F Moura Nunes; A L Clode; J D da Costa; M O Almeida
Journal:  Virchows Arch       Date:  1996-10       Impact factor: 4.064

6.  Role of p27Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer.

Authors:  H Kawana; J Tamaru; T Tanaka; A Hirai; Y Saito; M Kitagawa; A Mikata; K Harigaya; T Kuriyama
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

7.  Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma.

Authors:  H Kitamura; Y Kameda; N Nakamura; Y Nakatani; Y Inayama; M Iida; K Noda; N Ogawa; T Shibagaki; M Kanisawa
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

8.  Papillary adenoma of type II pneumocytes might have malignant potential.

Authors:  M Mori; R Chiba; F Tezuka; M Kaji; T Kobubo; T Nukiwa; T Takahashi
Journal:  Virchows Arch       Date:  1996-06       Impact factor: 4.064

9.  Idiopathic pulmonary fibrosis as a prognostic factor in non-small cell lung cancer.

Authors:  Taichiro Goto; Arafumi Maeshima; Yoshitaka Oyamada; Ryoichi Kato
Journal:  Int J Clin Oncol       Date:  2013-05-10       Impact factor: 3.402

Review 10.  C4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinoma.

Authors:  Benedikte Jacobsen; Mette Camilla Kriegbaum; Eric Santoni-Rugiu; Michael Ploug
Journal:  World J Clin Oncol       Date:  2014-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.